Online Programme

Search for the sessions or presentations

Found 135 Presentations
Live Streaming/On-demand
  • On-demand
 Filtered By

Sort By
On-demand

PG 2.2 - GIST and neuro-endocrine tumours

Presentation Number
PG 2.2
Speakers:
Session Name
PG 2 - There is more in the small bowel than Crohn’s disease: tumours and mimics
Channel
On-demand channel 1

Abstract

Learning objectives

To understand the imaging features and differential diagnoses of small bowel GISTs
To become familiar with the imaging features and differential diagnoses of small bowel neuro-endocrine tumours
To learn about the typical locations of small bowel GIST and neuro-endocrine tumours, and tumour types
Collapse

Video-on-demand

[session]
[presentation]
[presenter]
Collapse
On-demand

PG 4.1 - GI side effects of immunotherapy

Presentation Number
PG 4.1
Speakers:
Session Name
PG 4 - When GI immunity is at stake
Channel
On-demand channel 1

Abstract

Learning objectives

To know the GI side effects of immunotherapy
To understand the rad-path correlation of GI imaging findings related to immunotherapy
To learn the imaging findings of GI side effects and complications from immunotherapy

Collapse

Slides

Collapse

Video-on-demand

[session]
[presentation]
[presenter]
Collapse
On-demand

PG 4.2 - GI side effects of chemotherapy

Presentation Number
PG 4.2
Speakers:
Session Name
PG 4 - When GI immunity is at stake
Channel
On-demand channel 1

Abstract

Learning objectives

To know the GI side effects of chemotherapy
To understand the rad-path correlation of GI imaging findings related to chemotherapy
To learn the acute imaging features of neutropenic enterocolitis and the differential diagnosis

Collapse

Slides

Collapse
On-demand

PG 4.3 - GI manifestations of Graft versus Host Disease

Presentation Number
PG 4.3
Speakers:
Session Name
PG 4 - When GI immunity is at stake
Channel
On-demand channel 1

Abstract

Learning objectives

To know the GI manifestations of Graft versus Host Disease (relevant to the radiologist)
To understand the rad-path correlation of GI imaging findings in Graft versus Host Disease
To learn the imaging findings of Graft versus Host Disease and its complications
Collapse

Slides

Collapse
On-demand

ET 2.2 - MR enterography in Crohn’s disease

Presentation Number
ET 2.2
Speakers:
Session Name
ET 2 - MR enterography in Crohn’s disease #SINGLE TOPIC
Channel
On-demand channel 3

Abstract

Learning objectives

To learn the optimal imaging protocol for small bowel evaluation
To learn how different imaging features correlate with endoscopic findings
To learn how to make a structured report
Collapse

Slides

Collapse
On-demand

ET 4.2 - Benign gallbladder diseases

Presentation Number
ET 4.2
Speakers:
Session Name
ET 4 - Benign gallbladder diseases #SINGLE TOPIC
Channel
On-demand channel 5

Abstract

Learning objectives

To learn about the range of acute and chronic conditions that can affect the gallbladder
To learn about the role of different imaging techniques in the diagnosis of benign gallbladder disease
To be able to identify the imaging appearances of benign gallbladder disease and to know which features help to differentiate benign from malignant disease
Collapse

Slides

Collapse

Video-on-demand

[session]
[presentation]
[presenter]
Collapse
On-demand

ET 5.2 - Cholangiocarcinoma and mimics

Presentation Number
ET 5.2
Speakers:
Session Name
ET 5 - Cholangiocarcinoma and mimics #SINGLE TOPIC
Channel
On-demand channel 6

Abstract

Learning objectives

To become familiar with the typical growth patterns and imaging findings of both intra- and extrahepatic cholangiocarcinoma
To learn about the prevalence and clinical implications of mixed hepatocellular-cholangiocellular carcinoma
To describe those biliary tumours and pseudotumours that mimic cholangiocarcinoma
Collapse

Video-on-demand

[session]
[presentation]
[presenter]
Collapse
On-demand

GS 1.3 - ESGAR/SAR guideline quantification of diffuse liver diseases 2020

Presentation Number
GS 1.3
Speakers:
Session Name
GS 1 - New ESGAR guidelines: what do we learn for daily clinical practice
Channel
On-demand channel 1
On-demand

US 1.1 - Contrast-enhanced abdominal US

Presentation Number
US 1.1
Speakers:
Session Name
US 1 - Contrast-enhanced abdominal US
Channel
On-demand channel 8

Abstract

Learning objectives

To understand how easy CEUS of the abdomen is to perform and why it should be practiced in any Radiology department
To learn the common and uncommon indications of abdominal CEUS
To appreciate its value as a problem-solving modality in the abdomen, by confirming or elucidating CT or MR findings, by skipping these examinations altogether, or by even reaching a diagnosis when these, more sophisticated, modalities fail to do so
Collapse

Slides

Collapse

Video-on-demand

[session]
[presentation]
[presenter]
Collapse
On-demand

ET 6.1 - Interventional treatment of HCC

Presentation Number
ET 6.1
Speakers:
Session Name
ET 6 - Interventional treatment of HCC #SINGLE TOPIC
Channel
On-demand channel 3

Abstract

Learning objectives

To learn about the current options, indications and limitations of locoregional treatments for HCC
To become familiar with the assessment of treatment response after locoregional treatment
To understand the role of locoregional techniques in HCC treatment
Collapse

Slides

Collapse

Video-on-demand

[session]
[presentation]
[presenter]
Collapse
On-demand

ET 6.2 - Interventional treatment of HCC

Presentation Number
ET 6.2
Speakers:
Session Name
ET 6 - Interventional treatment of HCC #SINGLE TOPIC
Channel
On-demand channel 3

Abstract

Learning objectives

To learn about the current options, indications and limitations of locoregional treatments for HCC
To become familiar with the assessment of treatment response after locoregional treatment
To understand the role of locoregional techniques in HCC treatment
Collapse

Slides

Collapse

Video-on-demand

[session]
[presentation]
[presenter]
Collapse
On-demand

SS 1.2 - Prevalence of significant hepatic fibrosis using MR elastography in a health check-up clinic population

Presentation Number
SS 1.2
Speakers:
Session Name
SS 1 - Optimising assessment of chronic liver diseases
Channel
On-demand channel 4

Abstract

Purpose

Using MR elastography (MRE), we investigated the prevalence of significant fibrosis in a community-based cohort.

Material and methods

From January 2015 to May 2018, 2,170 participants receiving a health examination at our institution were enrolled in this study. All participants underwent MR chemical shift technique and MRE to assess liver fat and fibrosis, respectively. We also conducted subgroup analyses for participants with nonalcoholic fatty liver disease (NAFLD), metabolic syndrome, and diabetes mellitus (DM). For generalization, sex- and age-standardized prevalence estimates of hepatic fibrosis and fatty liver were also calculated based on the Korean Statistical Information Service (KOSIS) during 2015-2018.

Results

The prevalence of F2 (≥3.0 kPa) and F3 fibrosis (≥3.6 kPa) in the overall cohort was 5.1% and 1.3%, respectively (sex- and age-adjusted prevalence of 3.8% and 1.3%). NAFLD prevalence (>5% fat fraction) was 20.8% in the average-risk population (after excluding alcohol use and viral hepatitis), and the prevalence of significant and advanced fibrosis in NAFLD participants was 7.5% and 1.1%, respectively. The prevalence of DM was 7.7% in the overall cohort, with significant fibrosis in 13.7% and advanced fibrosis in 4.8%. In participants with fatty liver (of any etiology) plus diabetes, 27.5% had ≥F2 and 7.2% ≥F3. Multivariate analyses indicated that older age, insulin, diabetes, and fatty liver were independently associated with significant fibrosis.

Conclusion

In a health check-up clinic setting, the prevalence of significant and advanced fibrosis was 5.1% and 1.3% in (sex- and age-adjusted prevalence of 3.8% and 1.3%, respectively) and increased three- to fourfold with diabetes.

Collapse